Your browser doesn't support javascript.
loading
Effectiveness And Safety Of Ustekinumab Intensification At 90 Mg Every Four Weeks In Crohn's Disease: A Multicenter Study.
Fumery, Mathurin; Peyrin-Biroulet, Laurent; Nancey, Stephane; Altwegg, Romain; Gilletta, Cyrielle; Veyrard, Pauline; Bouguen, Guillaume; Viennot, Stephanie; Poullenot, Florian; Filippi, Jerome; Buisson, Anthony; Bozon, Anne; Brazier, Franck; Pouillon, Lieven; Flourie, Bernard; Boivineau, Lucile; Siproudhis, Laurent; Laharie, David; Roblin, Xavier; Diouf, Momar; Treton, Xavier.
Afiliación
  • Fumery M; Department of Gastroenterology, and PeriTox, UMR I0-I, Amiens University Hospital, Amiens, France.
  • Peyrin-Biroulet L; INSERM U1256 NGERE, Department of Gastroenterology, Nancy University Hospital, Lorraine University, Nancy, France.
  • Nancey S; Department of Gastroenterology, Hospices Civils de Lyon and University Claude Bernard Lyon 1, and INSERM U1111, CIRI, Lyon, France.
  • Altwegg R; Department of Gastroenterology, Hôpital Saint-Eloi, University Hospital of Montpellier, Montpellier, France.
  • Gilletta C; Department of Gastroenterology, Toulouse University Hospital, Toulouse, France.
  • Veyrard P; Department of Gastroenterology, Saint-Etienne University Hospital, Saint-Etienne, France.
  • Bouguen G; CHU Rennes, Univ Rennes, INSERM, CIC1414, Institut NUMECAN (Nutrition Metabolism and Cancer), Rennes, France.
  • Viennot S; Department of Gastroenterology, Caen University Hospital, Caen, France.
  • Poullenot F; CHU de Bordeaux, Hôpital Haut-Lévêque, Service d'Hépato-gastroentérologie et oncologie digestive - Université de Bordeaux, Bordeaux, France.
  • Filippi J; Department of Gastroenterology, Archet 2 University Hospital, Nice, France.
  • Buisson A; Université Clermont Auvergne, Inserm, U1071, M2iSH, USC-INRA 2018 3iHP, CHU Clermont-Ferrand, Service d'Hépato-Gastroentérologie, Clermont-Ferrand, France.
  • Bozon A; Department of Gastroenterology, IBD and Nutrition Support, Beaujon Hospital, Université de Paris site Denis Diderot, Clichy, France.
  • Brazier F; Department of Gastroenterology, and PeriTox, UMR I0-I, Amiens University Hospital, Amiens, France.
  • Pouillon L; INSERM U1256 NGERE, Department of Gastroenterology, Nancy University Hospital, Lorraine University, Nancy, France.
  • Flourie B; Department of Gastroenterology, Hospices Civils de Lyon and University Claude Bernard Lyon 1, and INSERM U1111, CIRI, Lyon, France.
  • Boivineau L; Department of Gastroenterology, Hôpital Saint-Eloi, University Hospital of Montpellier, Montpellier, France.
  • Siproudhis L; CHU Rennes, Univ Rennes, INSERM, CIC1414, Institut NUMECAN (Nutrition Metabolism and Cancer), Rennes, France.
  • Laharie D; CHU de Bordeaux, Hôpital Haut-Lévêque, Service d'Hépato-gastroentérologie et oncologie digestive - Université de Bordeaux, Bordeaux, France.
  • Roblin X; Department of Gastroenterology, Saint-Etienne University Hospital, Saint-Etienne, France.
  • Diouf M; Department of Biostatistics, Amiens University Hospital, Amiens, France.
  • Treton X; Department of Gastroenterology, IBD and Nutrition Support, Beaujon Hospital, Université de Paris site Denis Diderot, Clichy, France.
J Crohns Colitis ; 2020 Sep 08.
Article en En | MEDLINE | ID: mdl-32898232
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Idioma: En Revista: J Crohns Colitis Asunto de la revista: GASTROENTEROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Idioma: En Revista: J Crohns Colitis Asunto de la revista: GASTROENTEROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Francia